| Chicago Eye Center | |
|
4113 Saint Charles Rd, Bellwood, IL 60104-1145 | |
| (708) 493-9306 | |
| (708) 493-0144 |
| Full Name | Chicago Eye Center |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 4113 Saint Charles Rd, Bellwood, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255532248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 046009094 (Illinois) | Primary |
| Provider Name | Erwin P Cabela |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1992710578 PECOS PAC ID: 3870528722 Enrollment ID: I20050930000111 |
News Archive
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
A research group from Kumamoto University, Japan analyzed the pathophysiology of myelodysplastic syndrome (MDS), a blood cancer that presents often in the elderly, and found the presence of the transcription factor RUNX3, thereby revealing a cancer growth function for what had been considered a tumor suppressor.
A new guideline from the American Academy of Neurology, developed in full collaboration with the Child Neurology Society, finds that children with microcephaly that is, children whose head size is smaller than that of 97 percent of childrenare at risk of neurologic and cognitive problems and should be screened for these problems. The guideline is published in the September 15, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.
People with insomnia appear to be at increased risk for developing heart failure, findings from a large Norwegian cohort study show.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chicago Eye Center 4113 Saint Charles Rd, Bellwood, IL 60104-1145 Ph: (708) 493-9306 | Chicago Eye Center 4113 Saint Charles Rd, Bellwood, IL 60104-1145 Ph: (708) 493-9306 |
News Archive
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
A research group from Kumamoto University, Japan analyzed the pathophysiology of myelodysplastic syndrome (MDS), a blood cancer that presents often in the elderly, and found the presence of the transcription factor RUNX3, thereby revealing a cancer growth function for what had been considered a tumor suppressor.
A new guideline from the American Academy of Neurology, developed in full collaboration with the Child Neurology Society, finds that children with microcephaly that is, children whose head size is smaller than that of 97 percent of childrenare at risk of neurologic and cognitive problems and should be screened for these problems. The guideline is published in the September 15, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.
People with insomnia appear to be at increased risk for developing heart failure, findings from a large Norwegian cohort study show.
› Verified 4 days ago
Dr. Erwin Cabela, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4113 Saint Charles Rd, Bellwood, IL 60104 Phone: 708-493-9306 Fax: 708-493-0144 |